News & Events category:
News about Manchester Royal Infirmary
Early data for multivariant COVID-19 vaccine booster shows promise
The first results of an early trial of a multivariant COVID-19 vaccine booster, launched in Manchester in September 2021, has shown it is driving a comprehensive immune response.
Manchester Royal Infirmary researcher receives prestigious surgical honour
A trainee surgeon at Manchester Royal Infirmary (MRI) was recently awarded a prestigious national honour for his contributions to transplant research.
Action needed on high mortality in children with adrenal insufficiency
Children with adrenal insufficiency have a higher risk of dying than those with other lifelong conditions, according to research by The University of Manchester and MFT scientists.
Implantable tech could be a game-changer for heart patients
Implantable heart technology is being used in Manchester to assess when a patient is at high risk of dying, thanks to Manchester University NHS Foundation Trust-led research.
Rheumatoid Arthritis and predicting the future – Dr Stephanie Ling speaks to Arthritis Digest
Dr Stephanie Ling, Clinical Research Fellow at Manchester Royal Infirmary, discusses working with rheumatoid arthritis patients through research to improve biologic treatments.
Early trial of first multivariant COVID-19 vaccine booster begins in Manchester
A phase one trial of one of the world’s first multivariant COVID-19 Vaccine has been launched by US pharmaceutical company Gritstone, in collaboration with MFT.
Chief Operating Officer of CRN Greater Manchester participates in COVID-19 booster vaccine study at MFT
The Chief Operating Officer of the NIHR Clinical Research Network (CRN) Greater Manchester has volunteered to take part in a COVID-19 booster vaccine study.
Manchester IMID BioResource participant encourages young people to get involved in research
A young lupus patient is encouraging others to take part in research, after she volunteered for the NIHR Immune-Mediated Inflammatory Diseases (IMID) BioResource.